Sale!

Immunohistochemistry TLE1 1F5 Test Cost

Original price was: 550 د.إ.Current price is: 500 د.إ.

-9%

The Immunohistochemistry TLE1 1F5 Test is a specialized diagnostic procedure employed to detect the presence of the TLE1 protein in tissue samples, utilizing the 1F5 monoclonal antibody. This test is particularly significant in the context of diagnosing synovial sarcoma, a type of cancer that arises in the tissues surrounding joints and tendons, as TLE1 is commonly overexpressed in this malignancy. By applying the 1F5 antibody to tissue sections, pathologists can visually confirm the presence and distribution of TLE1 through a color change, providing crucial information for accurate diagnosis and treatment planning.

The test is available at DNA Labs UAE, a leading facility known for its advanced diagnostic services and commitment to quality healthcare solutions. The cost of the Immunohistochemistry TLE1 1F5 Test at DNA Labs UAE is set at 500 AED, making it accessible to patients requiring this specific diagnostic assessment. The integration of this test into the diagnostic process underscores the importance of targeted molecular diagnostics in contemporary cancer care, enabling more personalized and effective treatment approaches for patients with synovial sarcoma and potentially other TLE1-related conditions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY TLE1 1F5 Test

Test Cost: AED 500.0

At DNA Labs UAE, we offer the IMMUNOHISTOCHEMISTRY TLE1 1F5 test at a cost of AED 500.0. This test is used to detect the expression of the TLE1 protein in tissue samples.

Test Components

  • Price: 500.0 AED

Sample Condition

Please submit tumor tissue in 10% Formal-saline or Formalin fixed paraffin embedded block. The sample should be shipped at room temperature. Additionally, provide a copy of the Histopathology report, site of biopsy, and clinical history.

Report Delivery

Sample: Daily by 6 pm

Report Block: 5 days

Tissue Biopsy: 5 days

Tissue large complex: 7 days

Method

The IMMUNOHISTOCHEMISTRY TLE1 1F5 test utilizes immunohistochemical staining to detect the expression of the TLE1 protein. This test is commonly used in the diagnosis and classification of certain types of tumors.

Test Type

Cancer

Doctor

Oncologist, Pathologist

Test Department

HISTOLOGY

Pre Test Information

Please provide a copy of the Histopathology report, site of biopsy, and clinical history.

Test Details

The IMMUNOHISTOCHEMISTRY TLE1 (1F5) test is used to detect the expression of the TLE1 protein in tissue samples. TLE1 is a transcriptional corepressor protein involved in various cellular processes, including development and differentiation.

The 1F5 antibody is specifically designed to bind to the TLE1 protein and can be used to identify its presence in tissue sections. This test is commonly used in the diagnosis and classification of certain types of tumors, particularly in the field of pathology and oncology.

The immunohistochemistry technique involves staining tissue sections with the 1F5 antibody, followed by the addition of a secondary antibody that binds to the primary antibody. This secondary antibody is usually labeled with a detectable marker, such as a fluorescent dye or an enzyme. The presence of the TLE1 protein is then visualized under a microscope by detecting the signal from the marker.

The IMMUNOHISTOCHEMISTRY TLE1 (1F5) test can be used to identify TLE1 expression in various types of tumors, including synovial sarcoma, which is known to have high levels of TLE1 expression. The test can help differentiate synovial sarcoma from other types of tumors that may have similar histological features but lack TLE1 expression.

Overall, the IMMUNOHISTOCHEMISTRY TLE1 (1F5) test is a valuable tool in the field of pathology and oncology for the detection and classification of tumors based on TLE1 protein expression.

Test Name IMMUNOHISTOCHEMISTRY TLE1 1F5 Test
Components
Price 500.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Imunohistochemistry
Test type Cancer
Doctor Oncologist, Pathologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The IMMUNOHISTOCHEMISTRY TLE1 (1F5) test is a type of immunohistochemical staining used to detect the expression of the TLE1 protein in tissue samples. TLE1 stands for transducin-like enhancer of split 1 and is a transcriptional corepressor protein involved in various cellular processes, including development and differentiation.

The 1F5 antibody is specifically designed to bind to the TLE1 protein and can be used to identify its presence in tissue sections. This test is commonly used in the diagnosis and classification of certain types of tumors, particularly in the field of pathology and oncology.

The immunohistochemistry technique involves staining tissue sections with the 1F5 antibody, followed by the addition of a secondary antibody that binds to the primary antibody. This secondary antibody is usually labeled with a detectable marker, such as a fluorescent dye or an enzyme. The presence of the TLE1 protein is then visualized under a microscope by detecting the signal from the marker.

The IMMUNOHISTOCHEMISTRY TLE1 (1F5) test can be used to identify TLE1 expression in various types of tumors, including synovial sarcoma, which is known to have high levels of TLE1 expression. The test can help differentiate synovial sarcoma from other types of tumors that may have similar histological features but lack TLE1 expression.

Overall, the IMMUNOHISTOCHEMISTRY TLE1 (1F5) test is a valuable tool in the field of pathology and oncology for the detection and classification of tumors based on TLE1 protein expression.